MedTrace Logo

Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost

NCT02427945 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1671

Last updated 2019-03-19

No results posted yet for this study

Summary

The investigators are seeking to overcome the dual challenges of under-nutrition and diarrhea using an existing safe water supply platform to deliver nutrition information to targeted groups in Western Kenya. Using a randomized evaluation, investigators will determine the impact on nutrition status and practices of delivering nutrition information. The evaluation results will enable Evidence Action to make strategic decisions regarding the potential scale-up of the combined program across Kenya.

Conditions

  • Child Malnutrition

Interventions

BEHAVIORAL

Provision of information on safe water

A promoter from Evidence Action will visit the household and provide information on safe water.

BEHAVIORAL

Provision of information on safe water and child nutrition

A promoter from Evidence Action will visit the household and provide information on safe water, as well as child nutrition (including hygiene on food preparation and storage). Households will be given a poster to hang in their dwellings with basic nutrition information. The poster might be smaller and in black and white, or larger and in color.

Sponsors & Collaborators

  • Evidence Action

    collaborator UNKNOWN

  • MaiMwana

    collaborator UNKNOWN

  • Marcos Vera Hernandez

    lead OTHER

Principal Investigators

  • Marcos Vera-Hernandez, PhD · Research Fellow

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02427945 on ClinicalTrials.gov